Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet needs in the treatment of highly prevalent and progressive retinal diseases, including wet ...

For our methodology, we used a stock screener and selected healthcare stocks that had an RSI below 30, mid-market cap, and ...

Mark Yusko, Morgan Creek Capital Management CEO & CIO, is recommending investors sell Nvidia Corp (NASDAQ:NVDA) shares. Yusko ...

We recently published a list of 9 Buzzing AI Stocks to Watch on Latest News. In this article, we are going to take a look at ...

Semiconductor stocks were mostly higher on Monday, led by gains in Intel (NASDAQ:INTC), as traders looked to add to profits ...

Nvidia Corporation's (NASDAQ: NVDA) shares dipped 3.4% in response to its fiscal 2025 third-quarter results last week, but I ...